Alexion Pharmaceuticals

Alexion Pharmaceuticals

Employees:
3,100
Market Cap:
$28.61 billion
Revenue:
$3.09 billion
5 Year Trend:
31.5%
Net Income:
$432.67 million
NASDAQ:
ALXN
Founded:
1992

Alexion Pharmaceuticals Inc. is an American pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome and paroxysmal nocturnal hemoglobinuria. The company is also involved in immune system research related to autoimmune diseases. Wikipedia

Alexion Pharmaceuticals
Employees:
3,100
Market Cap:
$28.61 billion
Revenue:
$3.09 billion
5 Year Trend:
31.5%
Net Income:
$432.67 million
NASDAQ:
ALXN
Founded:
1992

Alexion Pharmaceuticals Inc. is an American pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome and paroxysmal nocturnal hemoglobinuria. The company is also involved in immune system research related to autoimmune diseases. Wikipedia